secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001140361-24-049137
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharmaceuticals raises ~$182.8M in public offering and private placement
-------------------------------------------------------------------------------

- Public offering of 15.18M shares at $12.50/sh, including full exercise of underwriters' option; net proceeds ~$178.1M.
- Private placement of 400,000 pre-funded warrants at $12.49 to RTW Innovation Master Fund, net proceeds ~$4.7M.
- Proceeds to fund pipeline development, commercialization preparedness, and general corporate purposes.
- 45-day lock-up on sales of common stock by officers, directors, and certain shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036124049137/0001140361-24-049137-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036124049137/ny20039717x4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-049137

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer